(Total Views: 184)
Posted On: 12/26/2023 4:10:55 PM
Post# of 67

$CYTK News Article - Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy https://marketwirenews.com/news-releases/cyto...30384.html


My Twitter: WhyteStocks